|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Tyson Bioresearch, Inc. (台欣生物科技研发)
Main Activities: Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Tyson Bioresearch, Inc. (台欣生物科技研发) Headquarters 5/F, 22, Ko Tong 3rd Rd., Chunan, Miaoli, Taiwan; Miaoli County; Miaoli County |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational Financial Auditors: Clock & Co., CPAs (2013) Incorporation Date: November 1, 1999 Total Employees: 135 Tel: 886-37-585988 |
|
Company Description |
| Founded in 1999, Tyson Bioresearch Inc. is a medical diagnostic manufacturing company dedicated to providing products and services to accelerate the development and commercialization of diagnostics. The company provides blood glucose testing instrument sets, human immunodeficiency virus (HIV) quick testing reagents, as well as hepatitis C virus (HCV) quick test reagents. The company supplies its products and services worldwide to research organizations, biomedical and medical device distribution | ||
|
||
Company Analysis |
| According to the Individual - Audited financial statement for the first two cumulated quarters of 2012, total net operating revenues increased with 42.41%, from TWD 88.64 millions to TWD 126.23 millions. Operating Results increased from TWD -6.32 millions to TWD 4.3 millions. The results of the period reached TWD 4.3 millions at the end of the period against TWD -6.32 millions last year. Return on equity (Net income/Total equity) went from -1.85% to 1.30%, the Return On Asset (Net income / Total Asset) went from -1.69% to 1.10% and the Net Profit Margin (Net Income/Net Sales) went from -7.13% to 3.41% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 18.62% compared to 9.81% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 9.24 to 4.99 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2012 Q2C (non-cons) |
2011 Y (non-cons) |
|
 | ||
| Audited | Audited | |
| ||
| TW Listed Company Financials | TW Listed Company Financials | |
| ||
| Unit | Millions | Millions |
| ||
Balance Sheet
| ||
Total Assets |
391 |
378 |
| ||
Current Assets |
293 |
279 |
| ||
Total Liabilities |
61 |
39 |
| ||
Shareholders Equity |
329 |
338 |
| ||
Current Liabilities |
58 |
37 |
| ||
| * All the accounts are in TWD. | ||
Income Statement
| ||
Total Operating Revenue |
126 |
192 |
| ||
Operational Profit (Loss) |
4 |
-9 |
| ||
Net Profit (Loss) |
4 |
-9 |
| ||
| * All the accounts are in TWD. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
1.1% |
-2.58% |
| ||
Annualised Return on Assets (ROA) |
2.2% |
-2.58% |
| ||
Return on Equity (ROE) |
1.3% |
-2.88% |
| ||
Annualised Return on Equity (ROE) |
2.6% |
-2.88% |
| ||
Return on Sales (ROS) |
3.41% |
-5.07% |
| ||
Return on Capital |
1.3% |
-2.88% |
| ||
Gross Profit Margin |
11.27% |
16.76% |
| ||
Operating Profit Margin |
-7.72% |
-6.32% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
3.52x |
14.68x |
| ||
Inventory Turnover |
1.53x |
3.28x |
| ||
Current asset turnover |
0.43x |
0.69x |
| ||
Fixed-asset turnover |
3.61x |
5.77x |
| ||
Asset Turnover |
0.32x |
0.51x |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
4 |
-9 |
| ||
EBITDA |
11 |
1 |
| ||
Enterprise value |
-118 |
-162 |
| ||
Enterprise Value / EBITDA |
-10.67 |
-82.57 |
| ||
Bookvalue (BV) |
274 |
283 |
| ||
Net Cash |
118 |
162 |
| Liquidity Ratios | ||
| ||
Current Ratio |
499.32% |
749.14% |
| ||
Quick ratio |
374.58% |
618.39% |
| ||
Doom's day ratio |
305.41% |
542.16% |
| ||
Cash Flow to Debt |
-24.94% |
40.55% |
| Leverage Ratios | ||
| ||
Leverage ratio |
118.63% |
111.79% |
| ||
Debt to equity |
18.62% |
11.79% |
| ||
Debt to total assets |
15.7% |
10.54% |
| ||
Debt / Enterprise Value |
-52.02% |
-24.52% |
| Trend Ratios | ||
| ||
Revenue Trend |
142.41% |
98.18% |
| ||
Net Income Trend |
-68.04% |
1,159.52% |
| ||
Operating Income Trend |
154.03% |
-1,125% |
| ||
 |